439 related articles for article (PubMed ID: 15058215)
1. [Disorder of adrenal gland function in chronic fatigue syndrome].
Zarković M; Pavlović M; Pokrajac-Simeunović A; Cirić J; Beleslin B; Penezić Z; Ognjanović S; Savić S; Poluga J; Trbojević B; Drezgić M
Srp Arh Celok Lek; 2003; 131(9-10):370-4. PubMed ID: 15058215
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
3. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers.
Scott LV; Medbak S; Dinan TG
Biol Psychiatry; 1999 Jun; 45(11):1447-54. PubMed ID: 10356627
[TBL] [Abstract][Full Text] [Related]
5. The low dose ACTH test in chronic fatigue syndrome and in health.
Scott LV; Medbak S; Dinan TG
Clin Endocrinol (Oxf); 1998 Jun; 48(6):733-7. PubMed ID: 9713562
[TBL] [Abstract][Full Text] [Related]
6. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
7. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
Cleare AJ; O'Keane V; Miell JP
Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921
[TBL] [Abstract][Full Text] [Related]
8. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
10. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome.
Scott LV; Medbak S; Dinan TG
Acta Psychiatr Scand; 1998 Jun; 97(6):450-7. PubMed ID: 9669518
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin and low-dose ACTH test in rheumatoid arthritis.
Foppiani L; Cutolo M; Sessarego P; Sulli A; Prete C; Seriolo B; Giusti M
Eur J Endocrinol; 1998 Mar; 138(3):294-301. PubMed ID: 9539304
[TBL] [Abstract][Full Text] [Related]
12. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
13. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
Inder WJ; Prickett TC; Mulder RT
Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
[TBL] [Abstract][Full Text] [Related]
14. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome.
Moorkens G; Berwaerts J; Wynants H; Abs R
Clin Endocrinol (Oxf); 2000 Jul; 53(1):99-106. PubMed ID: 10931086
[TBL] [Abstract][Full Text] [Related]
15. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
Scott LV; Burnett F; Medbak S; Dinan TG
Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
[TBL] [Abstract][Full Text] [Related]
16. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
[TBL] [Abstract][Full Text] [Related]
17. The 1microg short Synacthen test in chronic fatigue syndrome.
Hudson M; Cleare AJ
Clin Endocrinol (Oxf); 1999 Nov; 51(5):625-30. PubMed ID: 10594524
[TBL] [Abstract][Full Text] [Related]
18. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
[TBL] [Abstract][Full Text] [Related]
19. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of low dose ACTH stimulation test in suspected secondary adrenocortical insufficiency.
Gandhi PG; Shah NS; Khandelwal AG; Chauhan P; Menon PS
J Postgrad Med; 2002; 48(4):280-2. PubMed ID: 12571383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
